参考文献/References:
[1] 李建平,卢新政,霍勇,等.H型高血压诊断与治疗专家共识[J].中国医学前沿杂志:电子版,2016,8(5):23-28.
[2] Li Y,Fang W,Tao L,et al.Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage[J].Neuropsychiatr Dis Treat,2015,11(11):1231-1238.
[3] Stranger O,Herrmann W,Pietraik K,et al.DACH-LIGA homo-cysteine(German,Austrian and Swiss):concensus paper on the rational clinical use of homocysteine,folic acid and B-vitamins in cardiovascular and thrombotic diseases:guidelines and recom-mendations[J].Clin Chem Lab Med,2003,41(11):1392-1403.
[4] Towfighi A,Markovic D,Ovbiagele B.Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals:a nationwide study[J].J Neurol Sci,2010,298(1/2):153-157.
[5] 李建平.H型高血压诊断标准解读[J].中华高血压杂志,2017,[In press].
[6] kovierová H,Vidomanová E,Mahmood S,et al.The molecular and cellular effect of homocysteine metabolism imbalance on human health[J].Int J Mol Sci,2016,17(10):1733.
[7] Friso S,Choi SW,Girelli D,et al.A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status[J].Proc Natl Acad Sci U S A,2002,99(8):5606-5611.
[8] Lehotsk('overy)J,Tothová B,Kovalská M,et al.Role of homocysteine in the ischemic stroke and development of ischemic tolerance[J].Front Neurosci,2016,10(3389):538.
[9] Faraci FM,Hyperhomocysteinemia LS,Stress O.And cerebral vascular dysfunction[J].Stroke,2004,35(2):345-347.
[10] Sen U,Mishra PK,Tyagi N,et al.Homocystein to Hydrogen sulfide or hypertension[J].Cell Biochem Biophys,2010,57(2/3):49-58.
[11] Upchurch GR,Welch GN,Fabian AJ,et al.Stimulation of endothelial nitric oxide production by homocyst(e)ine[J].Atherosclerosis,1997,132(2):177-185.
[12] Yen CH,Ma YH,Yu HP,et al.Reduction of superior mesenteric hemodynamic responsiveness to[Sar1,Thr8]-angiotensin Ⅱ and bradykinin,but not Sodium nitroprusside,in the presence of homocysteine infusion[J].Chin J Physiol,2010,53(1):45-51.
[13] Huang A,Pinto JT,Froogh G,et al.Role of homocysteinylation of ACE in endothelial dysfunction of arteries[J].Am J Physiol Heart Circ Physiol,2015,308(2):H92-100.
[14] Li Z,Guo X,Chen S,et al.Hyperhomocysteinemia independently associated with the risk of hypertension:a cross-sectional study from rural China[J].J Hum Hypertens,2016,30(8):508-512.
[15] 葛均波,徐永健,梅长林,等.内科学[M].8版.北京:人民卫生出版社,2013:856-859.
[16] Lapi F,Azoulay L,Yin H,et al.Concurrent use of diuretics,angiotensin converting enzyme inhibitors,and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury:nested case-control study[J].BMJ,2013,346:e8525.
[17] Zhu JN,Qi XY,Tan Y,et al.Dietary factors associated with hyperuricemia and glycolipid metabolism disorder in middle-aged and elderly People[J].Sichuan Da Xue Xue Bao Yi Xue Ban,2016,47(1):68-72.
[18] Kanbay M,Solak Y,Dogan E,et al.Uric acid in hypertension and renal disease:the chicken or the egg?[J].Blood Purif,2010,30(4):288-295.
[19] 沈逸华,张玲玉,黄丽娟,等.高血压合并左心室肥厚患者血管内皮舒张功能与尿酸的关系[J].中华高血压杂志,2012,20(5):442-446.
[20] Johnson RJ,Kang DH,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?[J].Hypertension,2003,41(6):1183-1190.
[21] Netea MG,Kullberg BJ,Blok WL,et al.The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice[J].Blood,1997,89(2):577-582.
[22] Boan AD,Lackland DT,Ovbiagele B.Lowering of blood pressure for recurrent stroke prevention:topical review[J].Stroke,2014,45(8):2506-2513.
[23] Schaffer A,Verdoia M,Cassetti E,et al.Relationship between homocysteine and coronary artery disease.Results from a large prospective cohort study[J].Thromb Res,2014,134(2):288-293.
[24] Fu HJ,Zhao LB,Xue JJ,et al.Elevated serum homocysteine(Hcy)levels May contribute to the pathogenesis of cerebral infarction[J].Journal of Molecular Neuroscience,2015,56(3):553-561.
[25] 王冬梅,胡俊,傅冬梅.血浆中血脂类生化指标与脑血管病的相关性研究[J].中华老年心脑血管病杂志,2015,17(3):315-316.
[26] 孟令民,张彩凤,李俊捐,等.血尿酸与男性脑出血有关[J].中华高血压杂志,2014,22(3):267-271.
[27] Yu M,Sanchez LG,Johnson RJ,et al.Oxidative stress with an active of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction[J].J Hypertens,2010,28(6):1234-1242.
[28] 陈海霞.尿酸对血管内皮细胞氧化应激反应的影响及其对细胞的损伤作用[C]//中华医学会第十八次全国儿科学术会议论文集,长沙,2013:373-374.
[29] Griendling KK,Fitzgerald GA.Oxidative stress and cardiovascular injury:Part I:basic mechanisms and in vivo monitoring of ROS[J].Circulation,2003,108(16):1912-1916.
[30] Niwa K,Inanami O,Yamamori T,et al.Roles of protein kinase C delta in the accumulation of P53 and the induction of apoptosis in H2O2-treated bovine endothelial cells[J].Free Radic Res,2002,36(11):1147-1153.
[31] Hink HU,Santanam N,Dikalov S,et al.Peroxidase properties of extracellular superoxide dismutase:role of uric acid in modulating in vivo activity[J].Arterioscler Thromb Vasc Biol,2002,22(9):1402-1408.
[32] Cohen E,Levi A,Vecht-Lifshitz SE,et al.Assessment of a possible Link between hyperhomocysteinemia and hyperuricemia[J].J Investig Med,2015,63(3):534-538.
[33] Love BL,Barrons R,Veverka A,et al.Urate-lowering therapy for gout:focus on febuxostat[J].Pharmacotherapy,2010,30(6):594-608.
[34] Malik UZ,Hundley NJ,Romero G,et al.Febuxostat inhibition of endothelial-bound XO:Implications for targeting vascular ROS production[J].Free Radical Biology and Medicine,2011,51(1):179-184.